Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Effects of Mobility Dose on Discharge Disposition in Critically Ill Stroke Patients

Authors not listed

Beth Israel Deaconess Medical Center · 2017

Abstract

The primary aim of the study is to assess the mobility dose in neurocritical care patients with ischemic stroke or intracranial hemorrhage and its effects on discharge disposition and patient outcomes. The investigators hypothesize that patients' mobilization dose in the intensive care unit (ICU) predicts discharge disposition, 90 day Barthel Index and other outcomes like muscle wasting (expressed as decrease in rectus femoris cross sectional area (RF-CSA) in the paretic and non-paretic limb measured by bedside ultrasound), and ICU length of stay (LOS).

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-24 MST

Cite this

APA
Anonymous. (2017). Effects of Mobility Dose on Discharge Disposition in Critically Ill Stroke Patients. <em>Beth Israel Deaconess Medical Center</em>. https://clinicaltrials.gov/study/NCT03347656
Vancouver
Anonymous. Effects of Mobility Dose on Discharge Disposition in Critically Ill Stroke Patients. Beth Israel Deaconess Medical Center. 2017.
BibTeX
@misc{anon2017Effect, title = {Effects of Mobility Dose on Discharge Disposition in Critically Ill Stroke Patients}, author = {Anonymous}, journal = {Beth Israel Deaconess Medical Center}, year = {2017}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings